Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,906,288
+$16,383,423 QoQ
Shares Held
74,443
+621.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.08%
of 13F equity value
Holder Rank
#766
of 4,676 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TritonPoint Partners, LLC holds $38,756,371 across 9 Drug Manufacturers - General names. JNJ ranks #1 (48.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
74,443 | $18,906,288 | |
| 2 | MRK |
Merck & Co., Inc.
|
64,967 | $8,348,259 | |
| 3 | LLY |
ELI LILLY & Co
|
4,225 | $5,067,592 | |
| 4 | ABBV |
AbbVie Inc.
|
11,092 | $2,791,190 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
22,535 | $1,298,466 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,288 | $794,425 | |
| 7 | PFE |
Pfizer Inc
|
30,834 | $742,482 | |
| 8 | AMGN |
Amgen Inc
|
1,334 | $483,068 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,906,288 | 74,443 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,522,865 | 10,321 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,936,224 | 9,356 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||